ArticleBMJ open2025
Age, sex, income, sociodemographic and health system inequalities in the global burden of high systolic blood pressure: an analysis of the Global Burden of Disease Study 2021.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hypertension management in transition: gains, gaps, and growing challenges in a high-altitude multi-ethnic region of China (2019-2024).Annals of medicine · 2026Article
- Machine learning based variance estimation under two phase sampling using health and education sector data.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo examine the global and regional trends in disparities of high systolic blood pressure (HSBP) burden between 1990 and 2021 by age, sex, sociodemographic index and health systems' performance.
designSystematic analysis.
settingGlobal population-level data were extracted from the Global Burden of Disease (GBD) 2021 study covering all countries, grouped by World Bank income classifications and seven GBD super-regions. Health system performance was assessed using Healthcare Access and Quality Index categories.
participantsPopulation-level estimates including all age groups and sexes from 1990 to 2021 as captured in the GBD 2021 dataset were used. PRIMARY OUTCOME MEASURES: Age-standardised rates and counts of disability-adjusted life-years (DALYs), years of life lost (YLLs), years lived with disability (YLDs) and deaths attributable to HSBP, with 95% uncertainty intervals (UIs).
resultsFrom 1990 to 2021, the global number of DALYs, YLLs, YLDs and deaths related to HSBP increased for both sexes, with men experiencing a higher frequency. The global number of DALYs rose by 58.4% (95% UI: 48.1%, 69.9%), reaching 226 million (95% UI: 190, 259) in 2021, while deaths increased by 65.3% (95% UI: 54.2%, 77.3%), totalling 11 million (95% UI: 9, 13). Despite these increases, age-standardised rates of DALYs, deaths, YLDs and YLLs declined worldwide, with more significant decreases observed in women. Low-income and lower-middle-income countries, according to World Bank classification, faced the highest burden of HSBP in terms of DALY and death rates, whereas high-income countries reported the greatest reductions. The burden of HSBP also exhibited considerable variation by age, sex and income level, with older age groups bearing the heaviest burden. Regions with advanced health systems demonstrated significant declines in HSBP burden, while areas with minimal health systems experienced stable or slight decreases.
conclusionsThe burden associated with HSBP varied across age, sex, income levels, location and health system quality. Interventions should be tailored to these variations to mitigate this burden and address demographic disparities, socioeconomic factors and healthcare system differences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.